Long-term outcomes of surgical therapies for Parkinson's disease.
Maria C Rodriguez-Oroz, Elena Moro, Paul Krack
https://pubmed.ncbi.nlm.nih.gov/23208668/Actively Recruiting
Led by Swiss Federal Institute of Technology · Updated on 2024-12-03
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the neural mechanisms involved in movement among people with Parkinsons Disease PD to better understand gait patterns and inspire personalized treatments. This observational study compares brain activity during walking and seated stepping tasks between healthy individuals and PD patients. The study aims to identify neural biomarkers linked to gait by examining characteristic brain oscillations in both groups. Participants include 60 adults 30 healthy controls divided by age group under and over 45 years and 30 PD patients with postural instability and gait difficulties. All participants undergo a single 2.5-hour session involving standardized gait sequences and a seated lower limb motor task. Neural activity is recorded using EEG in all participants, and PD patients additionally have signals recorded from implanted deep brain stimulation DBS electrodes. A neuromodulation task is also explored in PD patients. During the session, movement parameters such as gait symmetry, coordination, variability, and resilience are measured using motion capture, electromyography EMG, and accelerometers. Electroencephalography and local field potentials from DBS electrodes capture brain activity. Researchers assess cortical activity underlying movement and compare it between healthy and PD participants. The study includes detailed motor tasks and short-term neuromodulation, with all recording devices being market-approved.
CONDITIONS
Investigating Neural Biomarkers for Gait in Parkinson's Patients
L
Lena Salzmann, MSc
O
Olivier Lambercy, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Swiss Federal Institute of Technology
Lead Sponsor
cereneo center for Neurology and Rehabilitation
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 2.5 hours
Participants undergo a single session where neural activity and gait-related movement parameters are recorded using EEG, accelerometers, electromyography, and motion capture. Parkinson's patients additionally participate in a neuromodulation task using deep brain stimulation electrodes.
1 session (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Maria C Rodriguez-Oroz, Elena Moro, Paul Krack
https://pubmed.ncbi.nlm.nih.gov/23208668/Werner Poewe, Klaus Seppi, Caroline M Tanner...
https://pubmed.ncbi.nlm.nih.gov/28332488/Deepak K Ravi, Michelle Gwerder, Niklas König Ignasiak...
https://pubmed.ncbi.nlm.nih.gov/31639377/Oliver Bichsel, Lennart H Stieglitz, Markus F Oertel...
https://pubmed.ncbi.nlm.nih.gov/33846456/Swiss Federal Institute of Technology
Lead Sponsor
cereneo center for Neurology and Rehabilitation
Collaborating Sponsor